Intended for healthcare professionals


Reliability of PSA testing remains unclear

BMJ 2003; 327 doi: (Published 25 September 2003) Cite this as: BMJ 2003;327:750
  1. Stefano Ciatto, head of department (
  1. Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta, I-50131 Florence, Italy

    EDITOR–Gottlieb's news item reports that the reliability of prostate specific antigen (PSA) testing is poor.1 Necropsy studies have for a long time shown that the prostate of men over 50 harbours cancer in about 30% of cases, but only 8-10% develop a …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription